65
Olema Pharmaceuticals, Inc. raises $250M under Reg D
Company raise · Raising · SAN FRANCISCO, CA · Form D filed 2024-12-12
$50M+ raiseFirst raise on EDGARPlacement agent engaged
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| David C. Myles, Ph.D. | Executive Officer |
| Sandra L. Horning, M.D. | Director |
| Scott L. Garland | Director |
| Sean Bohen, M.D., Ph.D. | Executive Officer, Director |
| Andrew C. Rappaport | Director |
| Graham L. Walmsley, M.D., Ph.D. | Director |
| Naseem C. Zojwalla, M.D. | Executive Officer |
| Yi C. Larson | Director |
| Cyrus L. Harmon, Ph.D. | Director |
| Shane C. Kovacs | Executive Officer |
| Ian L. Clark | Director |
| Gorjan L. Hrustanovic, Ph.D. | Director |
| Cynthia C. Butitta | Director |
Signed by Shane Kovacs, Chief Operating and Financial Officer.
Placement agents / sales compensation: Goldman Sachs & Co. LLC; LifeSci Capital LLC; Oppenheimer & Co. Inc.; H.C. Wainright & Co., LLChow; Citigroup Global Markets Inc.; J.P. Morgan Securities LLC; Jefferies LLC
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.